Bmyc is a member of the Myc family of transcriptional regulators in the mouse and the rat. It is predominantly expressed in hormonally controlled tissues, with highest level of expression in the epididymis. The BMYC protein has been shown to function as a transcription factor in vitro and to inhibit MYC. To study the significance of BMYC in vivo, a Bmyc knockout (KO) mouse model was generated by homologous recombination. The KO mice were viable and fertile and did not display gross morphological or histological changes compared to the WT mice. However, the testes and the epididymides of the KO mice were smaller than those of the WT mice. Correspondingly, a tendency for a lower sperm concentration in the cauda epididymides of the KO mice was detected. The testosterone produced/testis was significantly reduced, and accordingly, the LH levels were increased in the KO mice. Also, the expression levels of Myc and several of its target genes were elevated in the testes of prepubertal KO mice, whereas no differences in gene expression levels were detected in adult mice. Associated with the increased Myc expression, more apoptotic spermatogenic cells were detected in the seminiferous tubules of the KO mice. In conclusion, our data suggest that Bmyc is a regulator of Myc in vivo and that overexpression of Myc in the developing testis leads to increased apoptosis of spermatogenic cells.
Introduction
The epididymis is a mammalian organ responsible for post-testicular sperm maturation and storage of mature sperm. Recent advances in high-throughput genome approaches have led to an intensive search of genes coding for proteins involved in epididymal sperm maturation processes (Sipilä et al. 2009 ). As many of these genes are expressed exclusively in the epididymis, the identification of transcription factors regulating their expression is also of interest, although still only superficially known. Bmyc codes for a transcription factor abundantly expressed in the epithelial cells of the proximal caput epididymis, and the expression diminishes dramatically toward the cauda (Cornwall et al. 2001) .
Bmyc is a relatively poorly known member of the Myc family of transcriptional regulators. It was originally identified in the rat and named after its high expression in the brain (Ingvarsson et al. 1988) . Subsequently, an even higher expression was reported in the mouse epididymis where its expression is regulated by androgens (Gregory et al. 2000 , Cornwall et al. 2001 . Lower levels of expression have been detected in several other hormonally controlled tissues, including the adrenal, pituitary, prostate, ovary, and uterus, and the protein has also been detected in the hypothalamus and testis (Gregory et al. 2000) . In addition, Bmyc is the predominant Myc family gene expressed during mouse preimplantation development (Domashenko et al. 1997) .
The BMYC protein has high homology with the N-terminal domain of MYC and a unique 14 amino acid C-terminal domain that is not found in other MYC family proteins (Ingvarsson et al. 1988 , Asker et al. 1995 . BMYC lacks a nuclear localization signal and a basic helix-loop-helix leucine zipper (b-HLH-LZ) DNA binding domain typical for other MYC proteins that is also required for dimerization with MAX. However, it contains a transcriptional activation domain (TAD), localizes mainly in the nucleus, and has been shown in vitro to initiate transcription, to inhibit neoplastic transformation, and to inhibit transcriptional activation regulated by MYC (Resar et al. 1993 , Asker et al. 1995 . BMYC has also been shown to inhibit cellular proliferation (Gregory et al. 2000) .
The MYC-MAX complexes preferably recognize and bind to E-box sequences (CACGTG) in the genome (Blackwood & Eisenman 1991 , Henriksson & Luscher 1996 . As BMYC lacks the domain necessary for dimerization with MAX, it must mediate its gene expression regulatory actions via other mechanisms. Due to their high degree of homology, it has been suggested that transcriptional regulation may be partly mediated by competition for the same binding partners with MYC (Resar et al. 1993) . BMYC has also been shown to be phosphorylated in the TAD at sites conserved with MYC, which further implies interactions with the same partners (Gregory et al. 2000) . In addition to b-HLH-LZ-mediated binding, two regions responsible for other interactions, namely MYC boxes I and II (MBI and MBII), are well conserved amongs all MYC proteins (Henriksson & Luscher 1996) . MBII, in particular, has been identified as a critical domain in regulating virtually all biological activities of MYC (Cole & McMahon 1999) . MYC interacting proteins PFDN5 (MM1) and TBP have also been shown to bind to MBI and MBII domains of BMYC (Burton et al. 2006) .
So far no functional data for BMYC in the epididymis have been available. However, the expression of Bmyc was downregulated 500-fold and Myc was correspondingly upregulated 2.6-fold in caput epididymis of a mouse model for epididymal tumorigenesis (Sipilä et al. 2004) . Given the rarity of epididymal tumors (Ganem et al. 1998) , and the ability of BMYC to inhibit MYC-mediated neoplastic transformation (Resar et al. 1993) , this has led to hypothesis that BMYC could act as a tumor suppressor in the epididymis (Sipilä et al. 2004) . To address the role of Bmyc in epididymal tumorigenesis and in the development and function of the epididymis, in this study, we have created and characterized the Bmyc knockout (KO) mice.
Results

Generation of the Bmyc KO mice
Coding sequence of Bmyc was interrupted by targeted insertion of neomycin resistance gene (neo r ) cassette (Fig. 1A) . Correct targeting was confirmed by Southern hybridization and PCR, and loss of Bmyc mRNA from the caput epididymis was verified by RT-PCR (Fig. 1B, C and D). Male and female HE and KO mice were fertile and obtained litters comparable in size to WT mice (6.6G2.6, 7.7G2.9, and 7.7G1.8 pups/l for WT, HE, and KO breedings respectively with 14, 32, and 20 l studied respectively). However, Mendelian distribution of genotypes was not observed from HE!HE breedings; out of 260 genotyped pups, only 43 KO mice were observed, as opposed to the expected 65 (c 2 test, P!0.01), while no significant differences in gender distributions were detected. Otherwise the KO mice appeared healthy and normal. At the ages of 2 and 3 weeks, the KO males weighed significantly less than WT males (6.7G1.2 and 8.4G1.4 g at 2 weeks, nZ8 and 6 respectively and 9.4G1.3 and 11.2G1.1 g at 3 weeks, nZ19 and 7 respectively). A trend of decreased body weight was also detected in male KO mice over 4 weeks of age, but the weight difference was not statistically significant.
Changes in male reproductive organs in Bmyc KO mice
The weight of the testes and the epididymides of the KO as well as their weights relative to whole body weights were smaller than those of WT mice in all age groups studied ( Fig. 2A , B and C). As the weights of the testis and the epididymis are mainly constituted of the amounts of spermatozoa, sperm production was estimated by comparing caudal sperm concentrations in the 3-month-old WT and KO mice. The sperm concentrations measured for the KO and WT mice were 6.1G2.1!10 6 /ml and 7.4G4.5!10 6 /ml (nZ6 and 9) respectively. This is well in line with the detected decreases in adult testis (17%) and epididymis (15%) weights in the KO males. However, in contrast to that of the epididymis and testis weights, the difference in sperm concentrations did not reach the level of statistical significance. The KO spermatozoa appeared normal in morphology and in motility based on visual assessments. Histological analyses neither revealed gross abnormalities in the KO epididymides ( Fig. 2D and E). However, in two out of the 37 KO mice studied, atrophied testicular seminiferous tubules devoid of spermatogenic cells were observed. Furthermore, the diameter of the epididymal duct was significantly smaller in segment 3 of the KO caput epididymis compared with the WT mice (P!0.05; Fig. 2F ). However, no difference in diameters was detected in segment 4 (Fig. 2F ). According to the smaller sizes of the male reproductive organs, a lower testosterone production per testis was measured in adult KO compared with the WT mice (P!0.05; Fig. 3A ), and it was accompanied with a significant increase in serum LH levels in 3-month-old mice (P!0.01; Fig. 3C ).
In contrast to the reduced testosterone production, the serum level of testosterone was not significantly altered, and no difference was detected in FSH levels between the KO and WT mice ( Fig. 3B and D).
Changes in gene expression levels in Bmyc KO mice
We compared the expression levels of Myc and its direct downstream target genes Brca1, Cdk11b (Cdc2l1), Cdk4, and Mina between WT and KO mice in the testes and the epididymides at different ages. No changes in expression levels in the epididymis were detected, whereas Myc and Cdk4 were statistically significantly upregulated in the testes of 3-week-old KO mice (P!0.001 and P!0.01 respectively; Fig. 4A and B) while statistically significant increases were not identified for Cdk11b, Brca1, and Mina (Fig. 4C, D 
and E).
Apoptosis and cell proliferation in the testes of the Bmyc KO mice
The increased Myc expression prompted us to compare rates of proliferation and apoptosis in the testes between 3-week-old WT and KO mice. No changes in the amounts of proliferating cells as determined by Ki-67 staining were detected (Fig. 5A , B, C and D). However, TUNEL staining revealed significantly more apoptotic cells in the seminiferous tubules of the KO mice than in the WT mice, whereas the percentage of tubules with no apoptotic cells was significantly smaller in the KO than in the WT mice (Fig. 6A , B and C). At worst, the increased apoptosis resulted in seminiferous tubules completely devoid of spermatogenic cells (Fig. 6D ).
Induction of cell proliferation in the epididymides of the Bmyc KO mice
We also studied the putative role of BMYC in epididymal tumorigenesis by crossing the Bmyc KO mice with Gpx5-Tag2 transgenic mice (Sipilä et al. 2004) . In the mouse line with high SV40 Tag expression levels Gpx5-Tag1, 100% of mice develop tumors in the epididymis, whereas in the other mouse line with low SV40 Tag expression, GPX5-Tag2 mice, the T-antigen expression leads to hyperplastic epithelial changes and infertility, but no tumors are formed. Thus, the Bmyc KO mice were crossbred with GPX5-Tag2 mice expressing low levels of SV40 Tag in the epididymis to study whether the loss of Bmyc expression makes epididymis more susceptible to tumorigenesis. The data revealed that the loss of Bmyc did not induce tumorigenesis in the double transgenic mice, while the epididymal histology of the Bmyc KO/Gpx5-Tag2 mice was not distinguishable from the Gpx5-Tag2 mice used as a control. 
Discussion
As an inhibitor of MYC, BMYC is potentially an important regulator of several cellular processes ranging from proliferation and growth to apoptosis (reviewed in Hoffman & Liebermann (2008) and Albihn et al. (2010) ). The high expression of Bmyc in the blastocyst suggests involvement in early embryonic development, whereas in the adult the highest expression levels have been detected in hormonally controlled organs. Along with the ability to inhibit MYC, expression of Bmyc in the brain and the epididymis, organs with low incidence of primary tumors (reviewed in Ganem et al. (1998) and Salacz et al. (2011) ), suggests that BMYC may be a tumor suppressor. Furthermore, Bmyc expression was lost in a mouse model of epididymal tumorigenesis, and this was associated with an increased Myc expression and severe epididymal hyperplasia (Sipilä et al. 2004) . Although potentially an important transcriptional regulator, the role of BMYC has mainly been studied in vitro. To further increase our knowledge of its significance in vivo, we have generated and characterized a Bmyc KO mouse model. Despite its high expression in early embryonic development and the lethality caused by the loss of Myc or Mycn (Nmyc) (Davis et al. 1993 , Domashenko et al. 1997 , Hurlin 2005 , homozygous Bmyc KO mice were obtained. Although the KO mice proved mainly healthy and fertile, HE!HE breedings produced less homozygotes than expected by Mendelian distribution. Along with the detected smaller body weight of juvenile KO mice, this suggests a slight delay in the development of the KO embryos compared with the WT and KO embryos, leading to the detected increased mortality of the KO embryos in an environment shared with the normally developing WT and KO embryos. Although occasional embryo resorption sites were detected in uteri after HE!HE breedings, the underlying reason behind the decrease in the amount of KO pups from HE!HE breedings remains unknown.
The ability of BMYC to regulate gene transcription and its high expression in the epididymis suggested a role for the protein in the development or function of the epididymis. Although the KO mice were fertile, the epididymides were small in size and weighed less than the WT epididymides with a tendency for a lower sperm concentration in the cauda epididymis. While not statistically significant, the decrease in mean sperm concentrations corresponded with the decreased epididymal weights. Interestingly, the KO testes were also small, while testicular histology was normal in most of the KO animals. High serum LH levels indicate a hypogonal phenotype of the KO mice with a reduced capacity of the smaller testes to respond to pituitary LH stimulus. The serum testosterone concentration was, however, normalized by the increased LH stimulus, and the reduced epididymal size is, thus, likely to be caused mainly due to reduced luminal testosterone concentration.
Although the expression of Bmyc in the testis has not been previously reported, we set out to characterize Bmyc expression in the testes of juvenile mice, and, indeed, expression levels higher than in adults were detected. As BMYC has been shown to inhibit MYC in vitro, we estimated MYC activity in the testes of the Bmyc KO mice by measuring expression levels of Myc and its known target genes Brca1, Cdk11b, Cdk4 and Mina (Menssen & Hermeking 2002 , Tsuneoka et al. 2006 . Interestingly, the expression of Myc itself was significantly upregulated in the testes of 3-week-old KO mice, and similarly, upregulation of one of the Myc target genes, Cdk4, was detected. The upregulation of Myc expression suggests that either BMYC directly regulates the transcription of Myc or the increased MYC activity due to the loss of BMYC leads to an increase in its expression by an autoregulatory pathway.
Although Myc expression and function in the testis have not been extensively studied, transgenic mouse and rat (Kodaira et al. 1996 ) models overexpressing Myc in testicular cells have been generated. In both models, several founder lines displayed excessive apoptosis of spermatogenic cells and atrophy of the seminiferous tubules but also transgenic founder lines with morphologically normal testes were detected. However, the transgene expression levels of the different lines were not measured. A similar variable phenotype was detected in the KO mouse model of p19
Ink4d , an inhibitor of CDK4. Out of seven p19
Ink4d KO mice studied, two displayed atrophied seminiferous tubules (Buchold et al. 2007 ). Unfortunately, the authors did not measure Cdk4 expression levels. Thus, the required increase in Myc and/or Cdk4 expression causing apoptosis in spermatogenic cells is not known. In Bmyc KO mice, we detected 1.5-and 1.3-fold increases in the testicular expression levels of Myc and Cdk4 respectively. However, even these minor and transient changes in Myc and Cdk4 expression levels resulted into a clear increase in apoptosis in the testis and to the presence of seminiferous tubules devoid of spermatogenic cells with low incidence.
In conclusion, our data show that the loss of Bmyc causes upregulation of Myc during testicular development, and leads to increased apoptosis of spermatogenic cells in the seminiferous tubules, which results in smaller size of the testes and the epididymides. The smaller testes produce less testosterone, which is compensated by the increased LH production. These observations indicate that BMYC functions as a transcriptional regulator in vivo. The lower body weights of the juvenile Bmyc KO mice compared with WT mice indicate a role for BMYC during development in proliferating tissues. Also, as a regulator of Myc, the effect of BMYC during tumorigenesis is of interest and may warrant further studies with tumorigenic mouse models.
Materials and Methods
Generation of the Bmyc KO mice
A genomic BAC clone (RP22-380G15) containing the Bmyc locus was purchased from Children's Hospital Oakland Research Institute (Oakland, CA, USA). Cloning of the targeting construct was performed by the Red/ET recombination technology (Zhang et al. 1998 , Muyrers et al. 1999 . The coding sequence of Bmyc was interrupted by inserting a neo r in the exon 1 of the Bmyc gene, and the modified locus, with 15.3 kb upstream and 10.4 kb downstream homology arms (Fig. 1A) , was targeted to AB2.2 embryonic stem (ES) cells (Lexicon Genetics, Houston, TX, USA). The cells were cultured in the presence of geneticin (G-418, 350 mg/ml, Gibco, Invitrogen) for 8 days, and the antibiotic resistant colonies were picked, expanded, and stored frozen at K70 8C.
Correct targeting of the construct was assessed with negative backbone PCR (McDermott et al. 2004 ) and Southern hybridization. The negative backbone PCR was performed by amplifying a 576 bp fragment of the vector backbone with primers neoF and neoR (Table 1 ) and a native DyNAzyme I DNA Polymerase (FinnZymes Diagnostics, Espoo, Finland). Based on the results, more than 90% of the clones were excluded. Correct targeting in the remaining ES cell colonies was confirmed with Southern hybridization analyses. Genomic DNA (5-15 mg) was digested with SpeI (Promega), sizefractioned in 0.7% SeaKem Gold Agarose (Cambrex, East Rutherford, NJ, USA) gel, and transferred to Hybond XL (Amersham Biosciences) membranes. The membranes were hybridized overnight at 42 8C in ULTRAhyb buffer (Ambion, Austin, TX, USA) according to the manufacturer's protocol. A 600 bp-long PCR fraction 3 0 end of the Bmyc locus, labeled with [a-32 P]dCTP (Prime-a-Gene Labelling System, Promega), was used as a probe. The signal was detected with Fuji Super RX film (Fujifilm, Tokyo, Japan). The expected sizes for the WT and targeted alleles were 26.8 and 12.5 kb respectively. Chimeric mice were generated by injecting a correctly targeted ES cell clone into C57BL/6N blastocysts. Chimeric males were bred with C57BL/6N females to obtain heterozygous (HE) mice, which were further bred to obtain Bmycdeficient homozygous KO mice (Bmyc KO). The mice were genotyped by PCR using primers F1, R1, and R2 in the same reaction (Table 1) . The F1 and R1 primers amplified a 337 bp product of the targeted allele, and F1 and R2 primers amplified a 239 bp product of the WT allele. Absence of Bmyc mRNA from homozygotes was confirmed by RT-PCR using RNA extracted from the adult initial segment epididymis using the F1 and R2 primer pair.
Animal handling
All animal handling was conducted in accordance with Finnish Animal Ethics Committee and the institutional animal care policies of the University of Turku (Turku, Finland), which fully meet the requirements as defined in the NIH Guide on animal experimentation. Male KO and age-matched WT controls from mixed C57BL/6N-SV129 background were used throughout the study, except where otherwise noted. The animals were housed under controlled environmental conditions (12 h light:12 h darkness; temperature 21G1 8C) at the Animal Facility of the University of Turku. Soy-free SDS RM3 (Special Diet Service, Whitman, Essex, UK) and tap water were available ad libitum.
Histological analyses
The mice were anesthetized by i.p. injection of 400-600 ml 2.5% Avertin (2-2-2 tribromoethanol) and blood was collected by cardiac puncture. At the ages of 3 and 6 months, the mice were weighed, and thereafter, the tissues studied were dissected, weighed, and processed for histology. The testes were fixed in Bouin's solution (Sigma-Aldrich), and all other tissues were fixed in 4% paraformaldehyde (PFA). For histological analyses, the tissues were sectioned at 3-5 mm thickness and stained with Harris's hematoxylin and eosin (BDH Ltd., Poole, UK). At least five mice per group were analyzed. Testes and epididymides from 3-to 4-week-old WT and KO male mice were similarly collected.
Epididymal duct diameter was measured from histological sections from epididymal segments 3 and 4 (Abou-Haila & Fain-Maurel 1984) of 3-month-old WT and KO mice. Diameter was measured from five to ten separate duct cross sections of five mice, and a mean value was calculated for each mouse.
Immunohistochemical stainings
Apoptotic and proliferating cells in the testis and the epididymis were identified by TUNEL assay and Ki-67 labeling respectively. The tissues were PFA fixed, dehydrated, and sectioned at 3-5 mm thickness, and the tissue sections were deparaffinated and rehydrated in xylene and in a series of lowering concentrations of ethanol. Antigen retrieval was performed by boiling the sections in 10 mM sodium citrate in a pressure cooker. For TUNEL staining, the DNA ends were labeled with biotinylated dUTP nucleotides (30 nM; Roche Applied Science) by the terminal transferase enzyme (1 U/ml; Roche) and detected with TexasRed-conjugated avidin (1:50 dilution in TBS with 1% BSA; Invitrogen) and visualized under fluorescence microscope. Ki-67 staining was performed for similarly treated tissue sections with a goat polyclonal antiKi-67 antibody (1:1000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The primary antibody was detected with 
Sperm analyses
Sperm were collected from 2-to 6-month-old WT and KO mice. Cauda epididymis was dissected out and incubated in 400 ml Dulbecco's PBS at 37 8C for 15 min. Sperm were spread on object slides, air dried, and fixed for 1 h in a mixture of ethanol and acetic acid (2:1). After fixation, the slides were air dried, and sperm were stained with Harris' hematoxylin and eosin (BDH Ltd.). A series of dilutions was made from caudal sperm in Dulbecco's PBS, and the sperm were counted in a Bü rker haemocytometer chamber (Hawksley, Lancing, Sussex, UK).
Hormone measurements
Hormone measurements were carried out from serum samples collected from 3-month-old male WT and KO mice. Testosterone was measured from diethyl ether extracts using RIA (Huhtaniemi et al. 1985) , and FSH and LH were measured by immunofluorometric assays as described previously (Haavisto et al. 1993 , van Casteren et al. 2000 . Intratesticular testosterone was analyzed by homogenizing one weighed testis in 5 ml PBS from 11 KO and eight WT mice. The homogenates were diethyl extracted and measured by RIA (Spectric Kit, Orion Diagnostica, Finland).
RNA isolation, RT-PCR, and qRT-PCR
For RT-PCR, total RNA from testis and epididymides of 1-, 2-, 3-, 4-, and 8-week-old mice was isolated using TRIzol reagent (Invitrogen). RNA (1 mg) was treated with DNase (DNase I Amplification Grade Kit, Invitrogen) and a single-step RT-PCR was performed with AMV reverse transcriptase (Promega), RNasin Ribonuclease Inhibitor (Promega), and DyNAzyme II DNA polymerase (FinnZymes). From each sample, a minus-RT control was made by omitting AMV-RT from the reaction mix. Actb expression was determined as a control for RNA stability.
Induction of cell proliferation
Using a transgene consisting of a GPX5 promoter-driven large T-antigen, we have previously generated two transgenic mouse lines: one with high expression and epididymal tumors (GPX5-Tag1) and the other one with lower level of T-antigen expression leading to epididymal dysfunction and infertility, but no tumor formation (Sipilä et al. 2004) . In order to test the role of BMYC in cell proliferation and its potential role as tumor suppressor in the epididymis, the Bmyc KO mice were crossbred with the GPX5-Tag2 transgenic mice (Sipilä et al. 2004) . The epididymides were collected from 2-to 12-month-old Bmyc K/K ; GPX5-Tag2 C/WT mice, and Bmyc C/C ; GPX5-Tag2 C/WT mice were used as controls. Morphological and histological comparisons were performed as described earlier.
Statistical analyses
All statistical comparisons were performed using the SigmaPlot program (Systat Software, Inc., Point Richmond, CA, USA). All pairwise comparisons between WT and KO values were analyzed by t-test, except where otherwise noted. All error bars in figures indicate S.D.
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